VP, Clinical Trial Operations
Tue, Oct 24, 2023
Oct 24
5,200 shares @ $6.00
Increased holdings by +4.90%
21st largest trade (out of 43)
Positive 90D History
Trade made by an officer
100% win rate · +45.2% median edge vs SPY (11 trades, 90-day · small sample)
Insider trade was 69% below market price
Price 17% below 200-day moving average
Small Cap stock — insider trades carry more weight